CD5, a T-Cell surface glycoprotein, was mainly expressed on T cells and a small subset of normal B cells and was considered as an immunoregulatory biomarker in resectable non-small cell lung cancer and other cancer types (Moreno-Manuel et al., 2020). Here, CD5 is linked to cancer.